← AlphaSignal

Notes

Top 5 Undervalued US Common Stocks with Improving Fundamentals (October 31, 2026)

2026-10-31Screening report

Data as of 2026-10-31US market

Summary

Screened 12 undervalued US stocks on October 31, 2026; ADBE, PYPL, NKE, CVS, and LEN offer the strongest fundamental resilience, margin expansion, and valuation discounts for a 6 to 18 month horizon.

Screening weights

Fundamental improvement30%
Valuation25%
Balance sheet15%
Catalysts15%
Price dislocation10%
Risk5%

Candidate comparison

RankTickerSector3M returnRevenue YoYOPM ΔFCFScore
1
Adobe Inc.
Software-19.2%+10.6%+1.5%pPositive9.6
2
PayPal Holdings
Fintech-8.5%+8.2%+1.1%pPositive9.4
3
NIKE, Inc.
Consumer-14.2%+1.1%+0.4%pPositive9.1
4
CVS Health
Healthcare-6.0%+7.3%+1.0%pPositive8.8
5
Lennar Corporation
Homebuilding-11.8%+7.9%+0.2%pPositive8.7
6
Autodesk
Design Software-3.8%+16.0%+2.0%pPositive8.5
7
Western Digital
Storage Hardware-6.5%+23.8%+4.3%pPositive8.4
8
Lululemon Athletica
Consumer-18.2%+7.3%+0.4%pPositive8.2
9
Salesforce
Cloud CRM-10.5%+8.4%+3.2%pPositive8.0
10
J.B. Hunt Transport
Industrials-11.5%+4.8%+0.3%pPositive7.8
11
Starbucks
Restaurants-3.5%+2.2%+0.4%pPositive7.5
12
Intel
Semiconductors-28.6%+2.5%-2.1%pNegative5.8

Screened names (observations)

ADBEAdobe Inc.

Score: 9.6

Open ticker →

Observation

Exceptional valuation and cash-flow disconnect at $240-$245 multi-year lows, down 46% off peak following broader tech sector selloffs. Trades at an EV/FCF of ~9.3x and a free cash flow yield of ~10.8% (lower than 99% of its 10-year historical valuation range). Generates $2.2B+ in quarterly free cash flow ($8B+ annual run-rate) with 46% Non-GAAP operating margin and an active $25B share repurchase authorization retiring 29M shares YoY.

Catalysts to watch

  • Commercial monetization of Firefly video models and enterprise GenStudio contracts post-Adobe MAX
  • Oversold technical mean-reversion toward 20-day moving average
  • Aggressive multi-billion dollar open-market share repurchases

Risks

  • Generative AI design pricing competition
  • Enterprise creative sales cycle elongation

Framework exit signals

  • Digital Media net new ARR growth falls below +8% YoY
  • GAAP operating margin contracts below 32%

Metrics to watch

  • Digital Media net new ARR
  • Enterprise GenStudio customer adoption count

PYPLPayPal Holdings

Score: 9.4

Open ticker →

Observation

Compelling fundamental inflection post-Q3 earnings: delivered Q3 Non-GAAP EPS of $1.45 (beating estimates of $1.34 by $0.11) and raised full-year EPS guidance to ~$5.60. Trading at an attractive valuation (~10.0x-11.5x forward P/E, $55-$56) with Fastlane guest checkout conversion lifting checkout conversions by 80% and aggressive share repurchases retiring >7% of the float annually.

Catalysts to watch

  • Post-earnings guidance raise and multiple re-rating heading into peak holiday e-commerce shopping
  • Fastlane enterprise scaling across Shopify and major global merchant networks
  • Venmo monetization expansion via debit and merchant pay

Risks

  • Competition from Stripe and Apple Pay
  • Macro e-commerce consumer spending softness

Framework exit signals

  • TMD dollar growth turns negative YoY
  • Non-GAAP OPM falls below 16.5%

Metrics to watch

  • TMD growth YoY
  • Active accounts transaction volume

NKENIKE, Inc.

Score: 9.1

Open ticker →

Observation

High-conviction turnaround setup with Elliott Hill actively executing his strategic product and wholesale reboot as CEO. Trading at a multi-decade low multiple (~18x forward P/E, -60% off peak), Nike cleared negative guidance overhang in Q1. Re-engagement with wholesale retail partners (Foot Locker, running specialty doors) and $3.8B in annual FCF provide a resilient floor.

Catalysts to watch

  • Elliott Hill driving strategic realignment to core sport innovation and wholesale shelf-space recovery
  • Restoration of wholesale retail partner shelf-space across Foot Locker and specialty running doors
  • Inventory normalization paving the path for gross margin recovery in 2027

Risks

  • Greater China consumer spending recovery friction
  • Category competition from On and Hoka in performance running

Framework exit signals

  • North American wholesale order book contracts >8% YoY
  • Gross margin drops below 42.0%

Metrics to watch

  • Wholesale vs Direct-to-Consumer order velocity
  • Gross margin trajectory (%p)

CVSCVS Health

Score: 8.8

Open ticker →

Observation

High-yield turnaround compounder trading at ~10.8x forward P/E with a 3.0% dividend yield. Executive leadership transition under David Joyner provides immediate operational focus heading into Q3 earnings, Q2 Medical Benefit Ratio improved 250 bps YoY to 87.4%, and full-year CFFO is reaffirmed at $11.5B+.

Catalysts to watch

  • David Joyner CEO leadership restructuring driving healthcare operations execution
  • Multi-year Medicare Advantage margin recovery pathway
  • MinuteClinic and care delivery volume expansion

Risks

  • Medical cost utilization spikes in late 2026
  • PBM regulatory scrutiny

Framework exit signals

  • MBR exceeds 89.5% for two consecutive quarters
  • Operating margins compress >100 bps YoY

Metrics to watch

  • Health Care Benefits MBR
  • Annual operating cash flows

LENLennar Corporation

Score: 8.7

Open ticker →

Observation

Deep value dislocation at ~9.2x P/E with zero net homebuilding debt and $3.5B+ in cash reserves. Benefiting from secular structural US housing shortages, Lennar's disciplined land-light execution and targeted mortgage rate buydowns provide defensive downside safety despite rate volatility.

Catalysts to watch

  • Targeted mortgage rate buydowns sustaining high delivery volume into Q4
  • Consistent $250M quarterly share repurchase program
  • Resilient order backlogs supported by land-light balance sheet

Risks

  • Resurgent Treasury yield volatility delaying fall homebuyer traffic
  • Gross margin pressure from financing incentives

Framework exit signals

  • Homebuilding gross margin drops below 20.0%
  • Quarterly net deliveries fall >10% YoY

Metrics to watch

  • Homebuilding gross margin
  • Quarterly new orders count

Sources

AlphaSignal Research: Top 5 Undervalued US Common Stocks (Oct 31, 2026)

1. Executive Summary

Following a sharp tech-led selloff on October 30 driven by mounting AI infrastructure spending concerns, institutional capital rotation is accelerating into high-quality, cash-generative leaders trading at deep historical multiple discounts. By screening 12 US common stocks characterized by lagging 3-month price returns despite expanding quarterly operating profitability, steady revenue growth, and robust free cash flow, we finalized the Top 5 Undervalued US Stocks offering asymmetric risk/reward over a 6 to 18 month horizon.

2. Candidate Comparison Table

  1. ADBE (Score: 9.6) | Software | 3M Return: -19.2% | Rev Growth: +10.6% | OPM Change: +1.5%p | FCF: Positive
  2. PYPL (Score: 9.4) | FinTech | 3M Return: -8.5% | Rev Growth: +8.2% | OPM Change: +1.1%p | FCF: Positive
  3. NKE (Score: 9.1) | Consumer | 3M Return: -14.2% | Rev Growth: +1.1% | OPM Change: +0.4%p | FCF: Positive
  4. CVS (Score: 8.8) | Healthcare | 3M Return: -6.0% | Rev Growth: +7.3% | OPM Change: +1.0%p | FCF: Positive
  5. LEN (Score: 8.7) | Homebuilding | 3M Return: -11.8% | Rev Growth: +7.9% | OPM Change: +0.2%p | FCF: Positive
  6. ADSK (Score: 8.5) | 7. WDC (Score: 8.4) | 8. LULU (Score: 8.2) | 9. CRM (Score: 8.0) | 10. JBHT (Score: 7.8) | 11. SBUX (Score: 7.5) | 12. INTC (Score: 5.8)

3. Top 5 Detailed Breakdown

  • ADBE (9.6): Historic cash-flow dislocation at $240-$245 multi-year lows (EV/FCF ~9.3x, FCF yield ~10.8%); generates $2.2B+ quarterly FCF ($8B+ annual run-rate) with 46% Non-GAAP OPM and active $25B buybacks retiring 29M shares YoY.
  • PYPL (9.4): Q3 earnings beat (Non-GAAP EPS $1.45 vs $1.34 consensus), FY EPS guidance raised to ~$5.60; trading at ~10.0x-11.5x forward P/E ($55-$56) with Fastlane conversion lift 80% and >7% float retired annually via buybacks.
  • NKE (9.1): Multi-decade valuation low (~18x P/E, -60% off peak); Elliott Hill actively executing core sport innovation and wholesale shelf-space recovery, backed by $3.8B in annual FCF.
  • CVS (8.8): P/E ~10.8x, 3.0% dividend yield, David Joyner leading operational healthcare restructuring ahead of Q3 earnings, Q2 MBR improved 250 bps YoY to 87.4%, CFFO guidance reaffirmed at $11.5B+.
  • LEN (8.7): P/E ~9.2x with zero net homebuilding debt and $3.5B+ cash reserves; targeted rate buydowns and chronic US housing shortages provide strong downside floor.

4. Conclusion

  • Highest Conviction: ADBE
  • Best Post-Earnings Inflection: PYPL
  • Best Turnaround Catalyst: NKE
  • Best Management Catalyst: CVS
  • Best Balance Sheet & Value: LEN
  • Watchlist: ADSK, WDC, LULU, CRM

Not investment advice. Scores and lists are relative snapshots.

← All notes